
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1032 | 1117 | 1214 | 1346 | 2007 | 5733 |
Fund Return | 3.22% | 11.68% | 21.35% | 10.42% | 14.95% | 19.08% |
Place in category | 1396 | 852 | 1051 | 638 | 397 | 115 |
% in Category | 72 | 47 | 66 | 48 | 52 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology F | 1.22B | 3.22 | 10.42 | 19.08 | ||
GB00B5LXGG05 | 1.15B | 3.82 | 15.38 | 16.74 | ||
AXA Framlington Health Fund Z GBP A | 573.62M | 8.56 | 9.13 | 8.67 | ||
AXA Global Distribution R Acc | 266.84M | 5.74 | -1.26 | 4.97 | ||
AXA Global Distribution R Inc | 266.84M | 7.05 | -0.84 | 5.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund A DIST GBP | 41.24M | 18.73 | 11.59 | 20.94 | ||
Global Technology Fund W Acc GBP | 1.55B | 4.55 | 16.08 | 22.31 | ||
World Technology Fund D2g | 1.5B | 3.19 | 12.78 | 19.66 | ||
Global Technology Fund RG | 6.66B | 4.33 | 12.41 | 18.59 | ||
Global Technology Fund I G | 6.66B | 4.38 | 12.97 | 19.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Broadcom | US11135F1012 | 7.04 | 187.48 | +0.06% | |
Alphabet C | US02079K1079 | 6.46 | 172.61 | +2.34% | |
NVIDIA | US67066G1040 | 5.95 | 115.99 | +1.69% | |
Apple | US0378331005 | 4.94 | 235.93 | -0.88% | |
Meta Platforms | US30303M1027 | 4.58 | 640.00 | -2.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review